ChromaDex - About ChromaDex
ChromaDex - About ChromaDex

About ChromaDex

ChromaDex® is an innovative natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its unique business model which utilizes its wholly-owned synergistic business units, including ingredient technologies, natural product fine chemicals (known as “phytochemicals”), chemistry and analytical testing services  and product regulatory and safety consulting (as Spherix Consulting).  The Company provides seamless science-based solutions to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries. Our ingredient technologies unit includes products backed with extensive scientific research and intellectual property. The ingredient portfolio includes pTeroPure® pterostilbene; ProC3G®, a natural black rice containing cyanidin-3-glucoside; PURENERGY®, a caffeine-pTeroPure® co-crystal; nutraGac™, a gac fruit powder; curcumin, and NIAGEN®, its recently launched branded nicotinamide riboside, a novel next-generation B-vitamin.

In particular, ChromaDex®
  • Develops & markets phytochemical and botanical reference standards & materials
  • Develops & markets novel & natural products that have a positive impact on health
  • Brings safety & quality to the market with specialized services and scientific rigor

ChromaDex® was established in 1999 in response to growing demand for natural product reference standards, materials, and services. This growth has continued with increasing consumer and government demand for quality assurance methods across the spectrum of consumer-focused products.

Today, ChromaDex® continues it's leadership in the reference standards & services business with a customer-centric approach supported by scientific rigor. Its expertise in this market gives it a unique foundation for combining the power of nature with the science of health to develop & market natural & novel ingredients.

ChromaDex® is publicly-traded company (OTCQB:CDXC).